GlaxoSmithKline plc (GSKN) — Cash Flow Quality Index
GlaxoSmithKline plc (GSKN) has a Cash Flow Quality Index of 1.10x as of September 2025. Operating cash flow of MX$2.22 Billion exceeds net income of MX$2.01 Billion, indicating high earnings quality where cash backs reported profits. Explore GSKN cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GlaxoSmithKline plc Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for GlaxoSmithKline plc across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GSKN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for GlaxoSmithKline plc (2013–2024)
Year-by-year earnings quality comparison for GlaxoSmithKline plc. For live market cap and the full company financial profile, see GSKN company net worth.
| Year | Quality Index | Operating CF (MXN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.55x | MX$6.55 Billion | MX$2.58 Billion | ▲ +129.0% |
| 2023 | 1.11x | MX$5.48 Billion | MX$4.93 Billion | ▲ +124.5% |
| 2022 | 0.49x | MX$7.40 Billion | MX$14.96 Billion | ▼ -72.7% |
| 2021 | 1.81x | MX$7.95 Billion | MX$4.38 Billion | ▲ +23.5% |
| 2020 | 1.47x | MX$8.44 Billion | MX$5.75 Billion | ▼ -15.0% |
| 2019 | 1.73x | MX$8.02 Billion | MX$4.64 Billion | ▼ -25.7% |
| 2018 | 2.32x | MX$8.42 Billion | MX$3.62 Billion | ▼ -48.5% |
| 2017 | 4.52x | MX$6.92 Billion | MX$1.53 Billion | ▼ -36.6% |
| 2016 | 7.12x | MX$6.50 Billion | MX$912.00 Million | ▲ +2235.4% |
| 2015 | 0.31x | MX$2.57 Billion | MX$8.42 Billion | ▼ -83.8% |
| 2014 | 1.88x | MX$5.18 Billion | MX$2.76 Billion | ▲ +41.4% |
| 2013 | 1.33x | MX$7.22 Billion | MX$5.44 Billion | — |